Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans
Anthracyclines cause progressive cardiotoxicity whose ultimate severity is individual to the patient. Genetic determinants contributing to this variation are difficult to study using current mouse models. Our objective was to determine whether a spectrum of anthracycline induced cardiac disease can...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2019-08-01
|
Series: | G3: Genes, Genomes, Genetics |
Subjects: | |
Online Access: | http://g3journal.org/lookup/doi/10.1534/g3.119.400232 |
_version_ | 1819149169739169792 |
---|---|
author | Caroline J. Zeiss Daniel M. Gatti Olga Toro-Salazar Crystal Davis Cathleen M. Lutz Francis Spinale Timothy Stearns Milena B. Furtado Gary A. Churchill |
author_facet | Caroline J. Zeiss Daniel M. Gatti Olga Toro-Salazar Crystal Davis Cathleen M. Lutz Francis Spinale Timothy Stearns Milena B. Furtado Gary A. Churchill |
author_sort | Caroline J. Zeiss |
collection | DOAJ |
description | Anthracyclines cause progressive cardiotoxicity whose ultimate severity is individual to the patient. Genetic determinants contributing to this variation are difficult to study using current mouse models. Our objective was to determine whether a spectrum of anthracycline induced cardiac disease can be elicited across 10 Collaborative Cross mouse strains given the same dose of doxorubicin. Mice from ten distinct strains were given 5 mg/kg of doxorubicin intravenously once weekly for 5 weeks (total 25 mg/kg). Mice were killed at acute or chronic timepoints. Body weight was assessed weekly, followed by terminal complete blood count, pathology and a panel of biomarkers. Linear models were fit to assess effects of treatment, sex, and sex-by-treatment interactions for each timepoint. Impaired growth and cardiac pathology occurred across all strains. Severity of these varied by strain and sex, with greater severity in males. Cardiac troponin I and myosin light chain 3 demonstrated strain- and sex-specific elevations in the acute phase with subsequent decline despite ongoing progression of cardiac disease. Acute phase cardiac troponin I levels predicted the ultimate severity of cardiac pathology poorly, whereas myosin light chain 3 levels predicted the extent of chronic cardiac injury in males. Strain- and sex-dependent renal toxicity was evident. Regenerative anemia manifested during the acute period. We confirm that variable susceptibility to doxorubicin-induced cardiotoxicity observed in humans can be modeled in a panel of CC strains. In addition, we identified a potential predictive biomarker in males. CC strains provide reproducible models to explore mechanisms contributing to individual susceptibility in humans. |
first_indexed | 2024-12-22T13:57:20Z |
format | Article |
id | doaj.art-fabbdfebe0ba4b8d96fa418a6dcfb938 |
institution | Directory Open Access Journal |
issn | 2160-1836 |
language | English |
last_indexed | 2024-12-22T13:57:20Z |
publishDate | 2019-08-01 |
publisher | Oxford University Press |
record_format | Article |
series | G3: Genes, Genomes, Genetics |
spelling | doaj.art-fabbdfebe0ba4b8d96fa418a6dcfb9382022-12-21T18:23:31ZengOxford University PressG3: Genes, Genomes, Genetics2160-18362019-08-01982637264610.1534/g3.119.40023224Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in HumansCaroline J. ZeissDaniel M. GattiOlga Toro-SalazarCrystal DavisCathleen M. LutzFrancis SpinaleTimothy StearnsMilena B. FurtadoGary A. ChurchillAnthracyclines cause progressive cardiotoxicity whose ultimate severity is individual to the patient. Genetic determinants contributing to this variation are difficult to study using current mouse models. Our objective was to determine whether a spectrum of anthracycline induced cardiac disease can be elicited across 10 Collaborative Cross mouse strains given the same dose of doxorubicin. Mice from ten distinct strains were given 5 mg/kg of doxorubicin intravenously once weekly for 5 weeks (total 25 mg/kg). Mice were killed at acute or chronic timepoints. Body weight was assessed weekly, followed by terminal complete blood count, pathology and a panel of biomarkers. Linear models were fit to assess effects of treatment, sex, and sex-by-treatment interactions for each timepoint. Impaired growth and cardiac pathology occurred across all strains. Severity of these varied by strain and sex, with greater severity in males. Cardiac troponin I and myosin light chain 3 demonstrated strain- and sex-specific elevations in the acute phase with subsequent decline despite ongoing progression of cardiac disease. Acute phase cardiac troponin I levels predicted the ultimate severity of cardiac pathology poorly, whereas myosin light chain 3 levels predicted the extent of chronic cardiac injury in males. Strain- and sex-dependent renal toxicity was evident. Regenerative anemia manifested during the acute period. We confirm that variable susceptibility to doxorubicin-induced cardiotoxicity observed in humans can be modeled in a panel of CC strains. In addition, we identified a potential predictive biomarker in males. CC strains provide reproducible models to explore mechanisms contributing to individual susceptibility in humans.http://g3journal.org/lookup/doi/10.1534/g3.119.400232Anthracyclinescardiotoxicitybiomarkersfibrosismouse |
spellingShingle | Caroline J. Zeiss Daniel M. Gatti Olga Toro-Salazar Crystal Davis Cathleen M. Lutz Francis Spinale Timothy Stearns Milena B. Furtado Gary A. Churchill Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans G3: Genes, Genomes, Genetics Anthracyclines cardiotoxicity biomarkers fibrosis mouse |
title | Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans |
title_full | Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans |
title_fullStr | Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans |
title_full_unstemmed | Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans |
title_short | Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans |
title_sort | doxorubicin induced cardiotoxicity in collaborative cross cc mice recapitulates individual cardiotoxicity in humans |
topic | Anthracyclines cardiotoxicity biomarkers fibrosis mouse |
url | http://g3journal.org/lookup/doi/10.1534/g3.119.400232 |
work_keys_str_mv | AT carolinejzeiss doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans AT danielmgatti doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans AT olgatorosalazar doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans AT crystaldavis doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans AT cathleenmlutz doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans AT francisspinale doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans AT timothystearns doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans AT milenabfurtado doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans AT garyachurchill doxorubicininducedcardiotoxicityincollaborativecrossccmicerecapitulatesindividualcardiotoxicityinhumans |